Gynae BT 2017

Ongoing studies

POST-OP HIGH RISK CERVICAL CANCERS: Phase III Randomized Study of Concurrent Chemotherapy and Pelvic RT With or Without Adjuvant (Pacli + Carbo every 21 days x 4 cycles) Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy

RTOG-0724 Lead Group: RTOG

SWOG NSABP NCIC NCCTG GOG ECOG CALGB ACOSOG SWOG RTOG NSABP NCIC NCCTG ECOG CALGB ACOSOG

To Date: 163 Target: 400 (09/15/14)

GUSTAVE ROUSSY • Positive para-aortic nodes- completely resected, PET/CT negative (PET only required if positive para-aortic nodes during surgery) THÈME DU DIAPORAMA GOG-0263 Lead Group: GOG Patients with clinical stage IA2, IB or IIA squamous, adenosquamous, or adenocarcinoma of the cervix who have any/all of the following high-risk f atures after surgery: POST-OP INTERMEDIATE RISK CERVICAL CANCERS: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemo- radiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic LND dissection • Positive pelvic nodes • Positive parametrium

Target: 534